EN
EN
Pipeline Details
Pipelines
Targets
Indication
Discovery
Pre-clinical
Clinical Phase I
Clinical Phase II
ALPP ASPIRE-T
ALPP
Gynecological, Lung
I301 ASPIRE-T
IL13Rα2
Brain cancer
N201 TCR-T
NY-ESO-1
Sarcoma
L200 TCR-T
LMP2A
EBV-associated Cancers
H101 Neoantigen vaccine
H3.3-K27M
DMG
DLL3 ASPIRE-T
DLL3
ASPIRE-T
GPC3 ASPIRE-T
GPC3
Liver, Lung
BCMA ASPIRE-T
BCMA
MM
